2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; Giles, Rachel H.; Hora, Milan; Lam, Thomas B.; Ljungberg, Borje; Marconi, Lorenzo; Klatte, Tobias; Volpe, Alessandro; Abu-Ghanem, Yasmin; Dabestani, Saeed; Fernandez-Pello, Sergio; Hofmann, Fabian; Kuusk, Teele; Tahbaz, Rana; Powles, Thomas; Bex, Axel

dc.contributor.author	Bedke, Jens
dc.date.accessioned	2023-04-18T09:04:16Z
dc.date.available	2023-04-18T09:04:16Z
dc.date.issued	2022
dc.identifier.issn	0302-2838
dc.identifier.uri	http://hdl.handle.net/10900/139278
dc.language.iso	en	de_DE
dc.publisher	Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.eururo.2021.11.022	de_DE
dc.subject.ddc	610	de_DE
dc.title	2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02123
utue.publikation.seiten	134-137	de_DE
utue.personen.roh	Bedke, Jens
utue.personen.roh	Albiges, Laurence
utue.personen.roh	Capitanio, Umberto
utue.personen.roh	Giles, Rachel H.
utue.personen.roh	Hora, Milan
utue.personen.roh	Lam, Thomas B.
utue.personen.roh	Ljungberg, Borje
utue.personen.roh	Marconi, Lorenzo
utue.personen.roh	Klatte, Tobias
utue.personen.roh	Volpe, Alessandro
utue.personen.roh	Abu-Ghanem, Yasmin
utue.personen.roh	Dabestani, Saeed
utue.personen.roh	Fernandez-Pello, Sergio
utue.personen.roh	Hofmann, Fabian
utue.personen.roh	Kuusk, Teele
utue.personen.roh	Tahbaz, Rana
utue.personen.roh	Powles, Thomas
utue.personen.roh	Bex, Axel
dcterms.isPartOf.ZSTitelID	European Urology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	81	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE